Product Name: TAOK1-pS181
Product Number: AB-PK826
Size: 25 µg      Price:89.00
      $US
Target Full Name: Serine/threonine-protein kinase TAO1

Target Alias: FLJ14314; HKFC-B; KIAA1361; MAP3K16; MARKK; PSK2; STE20-like kinase PSK2; TAOK1; TAO kinase 1; KFC-B; MARKK; h KFC-B; ENSG00000160551

Product Type Specific: Protein kinase phosphosite-specific antibody

Antibody Code: PK826

Antibody Target Type: Phosphosite-specific

Antibody Phosphosite: S181

Protein UniProt: Q7L7X3

Protein SigNET: Q7L7X3

Antibody Type: Polyclonal

Antibody Host Species: Rabbit

Antibody Immunogen Source: Human TAO1 (TAOK1) sequence peptide Cat. No.: PE-04ALF99

Antibody Immunogen Sequence: PAN(pS)FVG(bA)C

Antibody Immunogen Description: Corresponds to amino acid residues P178 to G184; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.

Production Method: The immunizing peptide was produced by solid phase synthesis on a multipep peptide synthesizer and purified by reverse-phase hplc chromatography. Purity was assessed by analytical hplc and the amino acid sequence confirmed by mass spectrometry analysis. This peptide was coupled to KLH prior to immunization into rabbits. New Zealand White rabbits were subcutaneously injected with KLH-coupled immunizing peptide every 4 weeks for 4 months. The sera from these animals was applied onto an agarose column to which the immunogen peptide was thio-linked. Antibody was eluted from the column with 0.1 M glycine, pH 2.5. Subsequently, the antibody solution was neutralized to pH 7.0 with saturated Tris.This antibody was also subject to negative purification over phosphotyrosine-agarose.

Antibody Modification: Unconjugated. Contact KInexus if you are interest in having the antibody biotinylated or coupled with fluorescent dyes.

Antibody Concentration: 0.75 mg/ml

Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol

Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.

Product Use: Western blotting | Antibody microarray

Antibody Dilution Recommended: 2 µg/ml for immunoblotting

Antibody Potency: Weak to medium immunoreactivity of a target-sized protein by Western blotting in HeLa cells. Very strong immunoreactivity with immunogen peptide on dot blots.

Antibody Species Reactivity: Human

Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 110-125 kDa.

Antibody Specificity: High

Antibody Cross Reactivity: Almost no significant cross-reactivities except for a~ 77 kDa protein in HEK-293, HeLa, Jurkat and T98G cells.

Related Product 1: TAO1-pS181 blocking peptide

Related Product 2: TAO1-pY309 phosphosite-specific antibody (Cat. No.: AB-PK827)

Related Product 3: TAOSubtide - TAOK2 (PSK) protein kinase substrate peptide

Scientific Background: TAO1 (MAP3K16, TAOK1) is a protein-serine/threonine kinase of the STE group and STE20 family. It is involved in various processes such as p38/MAPK14 stress-activated MAPK cascade, DNA damage response and regulation of cytoskeleton stability. It phosphorylates MAP2K3, MAP2K6 and MARK2, and acts as an activator of the p38 (MAPK14) stress-activated MAPK cascade by phosphorylation and activation of the upstream MKK3 and MKK6 kinases. It is involved in G protein-coupled receptor signalling to p38 (MAPK14). In response to DNA damage, it is involved in the G2/M transition DNA damage checkpoint by activating the p38 (MAPK14) stress-activated MAPK cascade, probably by mediating phosphorylation of MKK3 (MAP2K3) and MKK6 (MAP2K6). It serves as a regulator of cytoskeleton stability by phosphorylating MARK2 at T208, leading to its activation and subsequent phosphorylation and detachment of MAPT/TAU from microtubules. It also regulates apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation via activation of the JNK (MAPK8) cascade.
Figure 1. Epitope mapping of TAO1-pS181 antibody with similar phosphopeptides on dot blots.


Figure 2. Identification of phosphosites related to TAO1-pS181.